Provides drug-by-disease insights and total disease market sizing by integrating disease segmentation with harmonized sales data.
~$275,000/yr est.
Monthly
1
1
Freshness
Recently enriched
Complete
44%
API
No API
Get an instant price estimate based on your organization profile — seats, usage rights, and contract term.Estimated ~$275,000/yr est.
Request a sample directly from IQVIA.
Expected fields and columns in this data product
MIDAS Disease is an alternative data product offered by IQVIA, available on discovery. Data is updated monthly. Vedex estimates pricing at roughly $275,000/yr (an estimate, not a vendor-published price).
Provides drug-by-disease insights and total disease market sizing by integrating disease segmentation with harmonized sales data.
IQVIA is a data provider vendor based in USA. PLEASE NOTE: Data availability in Snowflake is determined by your organization’s or customer’s data subscriptions with IQVIA. The licensing of these data assets are subject to local privacy laws, auth...